FRESENIUS MEDICAL CARE AG Fresenius Medical Care, the world's largest provider of dialysis products and services, expects material positive effects from the tax reform legislation signed into law in the United States today. The new law goes into effect on January 1, 2018.
In particular, the new legislation triggers the re-evaluation of deferred tax liabilities. This results in a one-time book gain of around 200 million Euros, to be reflected in 2017 Earnings After Tax.
On February 27, 2018 the company will release its 2017 business results and discuss the ongoing tax effect as part of its guidance for 2018.
FMC - Fresenius Medical Care AG & Co. KGaA published this content on 22 December 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 December 2017 20:49:02 UTC.
Original documenthttps://www.freseniusmedicalcare.com/en/news/details/title/ad-hoc-announcement-according-to-article-17-mar-fresenius-medical-care-expects-material-positive-effects-from-us-tax-reform/
Public permalinkhttp://www.publicnow.com/view/116B485BB867C1CF18580940119C97052F068D76
